Celebrating 20 years of innovation - Discover how we've been a catalyst for regional growth and UK innovation for over two decades in CPI's Annual Review 2023-2024.
From stress to Alzheimer’s: the potential applications of microbiome research
We’re starting to understand just how much our microbiome influences various aspects of our health. Here’s how that could unlock enormous opportunities.
Jun 17 2024
News
CPI appoints Professor Patrick Grant FREng, University of Oxford Pro-Vice-Chancellor for Research and Vesuvius Chair of Materials, as Non-Executive Director
The Royal Academy of Engineering Fellow and brings a wealth of experience in materials science to the CPI Board.
Evoralis receives half-a-million pound investment to accelerate its enzyme development to break down plastics for a truly circular economy.
Jun 12 2024
Blog
How innovation can create a more inclusive world
By embracing inclusivity, innovation can become a powerful tool for breaking down seemingly insurmountable barriers. Here’s how we’re driving this impact.
Jun 10 2024
Blog
Big Concepts in Brief: How is 5G being used in healthcare?
Bigger, better, faster. 5G technology isn’t just for mobile phones. Steven Bagshaw tells us how it’s laying the foundation for the hospital of the future.
Jun 07 2024
News
Textile manufacturing industry set for sustainable revolution
Waste2Fresh has created a large-scale demonstrator of a system designed to recycle wastewater from the denim manufacturing process.
Jun 07 2024
Blog
CPI’s two decades of extraordinary advances
As we celebrate 20 years of innovation and impact at CPI, let’s take a look at the past two decades and the advances we enabled with our expertise.
Jun 05 2024
News
CPI Enterprises invests in pioneering bioplastics firm
Floreon is redefining the plastics industry with renewable plant-based plastic and will receive a quarter-of-a-million investment from CPI Enterprises.
May 30 2024
Blog
Helping innovative companies get novel biological therapeutics to market
Biologics are transforming medicine. What are biologics? How is CPI using innovation to bring them to the market? Phillip Probert tells us more.
